跳至主要内容
临床试验/NCT02482909
NCT02482909终止不适用

A Prospective Randomized Study to Compare the Efficacy of Radiofrequency Ablation and Hepatic Resection as a Primary Treatment for Single Small Hepatocellular Carcinoma

Seoul National University Hospital0 个研究点目标入组 68 人开始时间: 2005年7月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
68
主要终点
The patient survival

研究概览

简要总结

The purpose of this prospective randomized study is to compare the efficacy and safety of radiofrequency ablation and hepatic resection for small hepatocellular carcinomas with very homogeneous underlying conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 20 and 70 years
  • Child-Pugh class A (score 5-6)
  • Single hepatocellular carcinoma
  • Maximal diameter of the tumor from 2 to 4 cm when measured on MRI or CT (The diameter on MRI was measured prior to that on CT)
  • No previous treatment
  • Platelet count > 80,000/mm3

排除标准

  • HCC abutting main hepatic veins or the first branches of the main portal vein
  • HCC abutting vessels ≥ 0.5 cm

结局指标

主要结局

The patient survival

时间窗: From the intervention up to 5 years or until the death of the participant whichever came first

次要结局

  • The disease-free survival(From the intervention up to 5 years or until hepatocellular carcinoma recurrence whichever came first)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyung-Suk Suh

Professor

Seoul National University Hospital

相似试验

A Study Comparing Radiofrequency Ablation and... | 临床试验